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Age-Speciﬁc Vascular Risk Factor Proﬁles According to Stroke
Subtype
Allard J. Hauer, MD; Ynte M. Ruigrok, MD, PhD; Ale Algra, MD, PhD; Ewoud J. van Dijk, MD, PhD; Peter J. Koudstaal, MD, PhD;
Gert-Jan Luijckx, MD, PhD; Paul J. Nederkoorn, MD, PhD; Robert J. van Oostenbrugge, MD, PhD; Marieke C. Visser, MD, PhD;
Marieke J. Wermer, MD, PhD; L. Jaap Kappelle, MD, PhD; Catharina J. M. Klijn, MD, PhD; On behalf of the Dutch Parelsnoer
Institute-Cerebrovascular Accident Study Group
Background-—Ischemic and hemorrhagic stroke are increasingly recognized as heterogeneous diseases with distinct subtypes and
etiologies. Information on variation in distribution of vascular risk factors according to age in stroke subtypes is limited. We
investigated the prevalence of vascular risk factors in stroke subtypes in relation to age.
Methods and Results-—We studied a prospective multicenter university hospital–based cohort of 4033 patients. For patients with
ischemic stroke caused by large artery atherosclerosis, small vessel disease, or cardioembolism and for patients with spontaneous
intracerebral hemorrhage or aneurysmal subarachnoid hemorrhage, we calculated prevalences of vascular risk factors in 4 age
groups: <55, 55 to 65, 65 to 75, and ≥75 years, and mean differences with 95% CIs in relation to the reference age group. Patients
aged <55 years were signiﬁcantly more often of non-white origin (in particular in spontaneous intracerebral hemorrhage and
aneurysmal subarachnoid hemorrhage patients) and most often smoked (most prominent for aneurysmal subarachnoid
hemorrhage patients). Patients aged <55 years with ischemic stroke caused by large artery atherosclerosis or small vessel disease
more often had hypertension, hyperlipidemia, and diabetes mellitus than patients with ischemic stroke of cardiac origin. Overall,
the frequency of hypertension, hyperlipidemia, and diabetes mellitus increased with age among all stroke subtypes, whereas
smoking decreased with age. Regardless of age, accumulation of potentially modiﬁable risk factors was most pronounced in
patients with ischemic stroke caused by large artery atherosclerosis or small vessel disease.
Conclusions-—The prevalence of common cardiovascular risk factors shows different age-speciﬁc patterns among various stroke
subtypes. Recognition of these patterns may guide tailored stroke prevention efforts aimed at speciﬁc risk groups. ( J Am Heart
Assoc. 2017;6:e005090. DOI: 10.1161/JAHA.116.005090.)
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S troke is the second cause of death worldwide,
1 and the
third most common cause of disability.2 Traditionally,
the main stroke subtypes are ischemic stroke (IS), sponta-
neous intracerebral hemorrhage (sICH), and aneurysmal
subarachnoid hemorrhage (aSAH). Eighty to 90% of the risk
of both IS and intracerebral hemorrhage (ICH) is attributable
to common vascular risk factors, including hypertension,
smoking, obesity, diet, physical inactivity, diabetes mellitus,
alcohol intake, and unfavorable lipid proﬁle.3 IS and sICH are
increasingly recognized as heterogeneous diseases with
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distinct subtypes, etiologies, and epidemiological patterns.
Consequently, vascular risk proﬁles may differ according to
stroke subtype and age. However, information on the
variation in distribution of vascular risk factors according
to age in stroke subtypes is limited,3,4 although there are
studies that report speciﬁcally on risk factors for stroke in
the young and in the elderly.5–9
We investigated age-speciﬁc prevalences of vascular risk
factors in patients with IS and its subtypes, sICH, and aSAH in
a prospective multicenter hospital-based cohort in The
Netherlands.
Methods
Study Population and Deﬁnition of Stroke
We included patients with cerebral ischemia, including both IS
and transient ischemic attack (TIA), sICH, or aSAH who were
enrolled in an ongoing prospective registry of 8 university
hospitals between September 2009 and November 2014 in
The Netherlands.10 In this study, the so-called Parelsnoer
Initiative, clinical data, imaging, and biomaterials of patients
with stroke are prospectively and uniformly collected.10 We
approached all eligible patients, or a next of kin when patients
were unconsciousness or mentally incompetent, for informed
consent within the ﬁrst 3 months after the event. For
simplicity, we used IS to refer to patients with IS or TIA. IS,
sICH, and aSAH were deﬁned according to the World Health
Organization criteria for stroke and TIA,11 and conﬁrmation on
computed tomography or magnetic resonance imaging was
required for sICH and aSAH.
We further classiﬁed IS into speciﬁc subtypes according
to Trial of Org 10172 in Acute Stroke Treatment (TOAST)
classiﬁcation:12 large artery atherosclerosis (LAA), small
vessel disease (SVD), cardioembolic stroke, other deter-
mined cause, and undetermined cause.12 For the current
analyses we only included the IS subtypes LAA, SVD, and
cardioembolic stroke because both IS of other determined
cause and of undetermined origin represent a variety of
diseases. ICH was deﬁned as spontaneous when presumably
caused by rupturing of small vessels in the presence of
hypertension or cerebral amyloid angiopathy. We excluded
ICH patients with known macrovascular causes (eg, arteri-
ovenous malformation, dural arteriovenous ﬁstula, caver-
noma, cerebral venous sinus thrombosis), tumor, or other
rare causes. We deﬁned aSAH by the presence of subarach-
noid blood on noncontrast computed tomography compatible
with a ruptured aneurysm and an aneurysm on computed
tomography, magnetic resonance imaging, or digital subtrac-
tion angiography.
The ethics committees of all participating centers approved
the study and all patients provided written informed consent.
Assessment of Risk Factors
We dichotomized ethnicity between white versus non-white
origin. We deﬁned obesity as a BMI ≥30 kg/m2, calculated
by dividing weight in kilograms by the square of height in
meters. We deﬁned hypertension as ever or current
diagnosis or treatment with antihypertensive drugs,
whereas diabetes mellitus was deﬁned as ever or current
diagnosis or treatment with antidiabetic drugs. Total
cholesterol >3.5 mmol/L, low-density lipoprotein choles-
terol >2.5 mmol/L, or treatment with lipid-lowering agents
was considered as hypercholesterolemia. Information about
these modiﬁable risk factors was obtained by consulting
the patients’ medical records or general practitioners. We
deﬁned smoking as current or recently stopped, in which
“recently” was deﬁned as less than 6 months. Lastly,
family history of early-onset cardiovascular disease was
considered positive in the case of a ﬁrst-degree relative
with a past vascular event, which included IS, ICH, SAH,
myocardial infarction, and peripheral artery disease, before
the age of 60 years for patients with either IS or sICH. For
patients with aSAH, we considered the family history as
positive in the case of at least one ﬁrst-degree relative
with aSAH.
Statistical Analysis
We deﬁned 4 age groups of comparable size: <55 years
(n=1004, 24.9%), 55 to 65 years (n=943, 23.4%), 65 to
75 years (n=1053, 26.1%), and ≥75 years (n=1033, 25.6%).
For each stroke subtype, we used the age group that
contained the median age of that speciﬁc stroke type as a
reference. For IS and sICH, the reference was the age group of
65 to 75 years, and for aSAH this was the age group of 55 to
65 years. For each stroke subtype, we calculated frequencies
of risk factors in each age group and subsequently mean
differences (MDs) in prevalence with corresponding 95% CIs
for each age group in relation to the reference age group.
Finally, we determined the number of potentially modiﬁable
risk factors (obesity, hypertension, hyperlipidemia, diabetes
mellitus, and smoking) in each age group for each stroke
subtype. For this ﬁnal analysis, we imputed missing data of
height (21.8%), weight (19.6%), hypertension (1.2%), hyper-
lipidemia (2.6%), diabetes mellitus (1.5%), and smoking status
(5.2%) by multiple imputation using linear regression.
Results
Baseline Characteristics and Distribution of
Stroke
We included 4033 patients: 3311 patients with IS, 294
patients with sICH, and 428 patients with aSAH. In 58.5%
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of the patients with cerebral ischemia, symptoms persisted
for more than 24 hours. Distribution of stroke subtypes,
and their age distribution, is shown in Table 1. The median
age of patients was 65.6 years (interquartile range, 55.1–
73.3) and 2252 (55.8%) were men. Baseline characteristics
of the cohort are presented in Table 2. History of
cardiovascular disease was present in 1288 (31.9%)
patients, and in 943 (23.4%) patients this history included
stroke.
Ischemic Stroke Overall
We found male predominance among all age groups, most
prominently in patients aged 55 to 75 years (Figure 1A;
Table S1). Patients aged <55 years (7.5%) or 55 to 65 years
(6.8%) were signiﬁcantly more often non-white than those in
the reference age group of 65 to 75 years (3.8%; Figure 2A;
Table S2). Compared with the reference group, patients
aged ≥75 years were signiﬁcantly less often obese (MD,
7.0%; 95% CI, 11.0 to 3.1), whereas prevalences of
obesity were similar among the other age groups (20%)
(Figure 2A). Prevalence of hypertension increased with age.
Prevalences of hyperlipidemia and diabetes mellitus
increased up to the age of 75 years, and declined
thereafter. Smoking was the most prevalent modiﬁable risk
factor among the youngest (43.9%) group, and decreased
with age, especially after the age of 65 years (Figures 1A
and 2A). Patients aged ≥75 years signiﬁcantly less often
reported a family history of early-onset cardiovascular
disease (Figure 2A) than younger patients.13 The total
number of potentially modiﬁable risk factors increased up
to the age of 75 years, and declined thereafter (Figure 3A;
Table S3).
Ischemic Stroke Caused by Large Artery
Atherosclerosis
We found male predominance among all age groups
(Figure 1B; Table S4). Obesity was most prevalent in the
youngest group (30.3%). Hypertension was present in >50% in
all age groups. The prevalence of hyperlipidemia increased up
to the age of 75 years, whereas it declined thereafter
(Figure 2B; Table S5). Diabetes mellitus was found most often
in patients aged 65 to 75 years (25.7%), but also in 15.7% of
those aged <55 years (Figure 1B). Compared with the refer-
ence age group, patients <65 years smoked signiﬁcantly more
often, and those ≥75 years signiﬁcantly less (Figure 2B). A
family history of early-onset cardiovascular disease was
signiﬁcantly more often reported by those aged <55 years
(55.6%) in comparison with the reference group (42.1%), and
signiﬁcantly less by those aged ≥75 years (27.7%) (Figure 2B).
Accumulation of at least 2 potentially modiﬁable risk factors
was seen in more than half the patients (Figure 3B; Table S3).
Table 1. Stroke Distribution in the Dutch Parelsnoer
Institute-Cerebrovascular Accident Study
No. (%) Age, Median (IQR)
Ischemic stroke* 3311 (82.1) 66.7 (56.4–76.2)
Large artery atherosclerosis† 815 (24.6) 68.2 (61.6–76.7)
Small vessel disease† 632 (19.1) 66.1 (58.0–75.8)
Cardioembolic stroke† 467 (14.1) 72.2 (62.2–80.4)
Other determined cause† 214 (6.5) 51.1 (42.8–64.4)
Undetermined stroke† 1130 (34.1) 65.6 (54.0–75.3)
Spontaneous intracerebral
hemorrhage
294 (7.3) 65.7 (55.0–73.8)
Aneurysmal subarachnoid
hemorrhage
428 (10.6) 56.7 (48.4–65.5)
IQR indicates interquartile range.
*In 53 (1.6%) patients with ischemic stroke, a Trial of Org 10172 in Acute Stroke
Treatment (TOAST) classiﬁcation was lacking.
†The percentages reported are as part of total ischemic stroke.
Table 2. Baseline Characteristics of Patients Included in the
Dutch Parelsnoer Institute-Cerebrovascular Accident Study
N=4033
Men 2252 (55.8)
Age, median (IQR) 65.6 (55.1–75.3)
Non-white 187/3507 (5.3)
Cardiovascular risk factors:
Hypertension 2102/3985 (52.7)
Hyperlipidemia 1277/3928 (32.5)
Diabetes mellitus 573/3973 (14.4)
Current smoker 1201/3822 (31.4)
Family history of early-onset vascular events* 951/2621 (36.3)
Familial history of subarachnoid hemorrhage† 27/301 (8.2)
Obesity 547/3108 (17.6)
Cardiovascular history
Ischemic stroke (including TIA) 939/3768 (24.9)
Intracerebral hemorrhage 63/3754 (1.7)
Subarachnoid hemorrhage 50/3759 (1.3)
Myocardial infarction 409/3984 (10.3)
Atrial fibrillation‡ 398/3232 (12.3)
Peripheral artery disease 307/3954 (7.8)
Any cardiovascular history 1288/3667 (35.1)
Values are expressed as numbers (percentages) unless otherwise indicated. IQR
indicates interquartile range; TIA, transient ischemic attack.
*Any vascular bed included; not collected in patients with aneurysmal subarachnoid
hemorrhage.
†In a ﬁrst-degree relative; only collected in patients with aneurysmal subarachnoid
hemorrhage.
‡Medical history of atrial ﬁbrillation was only routinely collected in patients with cerebral
ischemia.
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Ischemic Stroke Caused by Small Vessel Disease
In patients with IS caused by SVD, we found a higher
prevalence of men than women only in those aged <65 years
(Figure 1C; Table S6). The proportion of patients of non-white
origin declined with age. Obesity was most frequent among
the youngest age group (28.3%). Hypertension (45.8%),
hyperlipidemia (32.5%), and diabetes mellitus (18.6%) were
all frequent in patients with IS caused by SVD aged <55 years
and the prevalence of these risk factors generally increased
Figure 1. Prevalences of vascular risk factors according to age group. Ischemic stroke overall (A); ischemic stroke caused by
large artery atherosclerosis (B), small vessel disease (C), or cardioembolism (D); spontaneous intracerebral hemorrhage (E); and
aneurysmal subarachnoid hemorrhage (F).
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Figure 2. Age-speciﬁc trends in vascular risk factors. The forest plots show the mean differences with accompanying 95%
CIs in the prevalences of the vascular risk factors for each age group in relation to that of the reference age group (65–
75 years for ischemic stroke and intracerebral hemorrhage and 55–65 years for aneurysmal subarachnoid hemorrhage).
Ischemic stroke overall (A); ischemic stroke caused by large artery atherosclerosis (B), small vessel disease (C), or
cardioembolism (D); spontaneous intracerebral hemorrhage (E); and aneurysmal subarachnoid hemorrhage (F).
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with age (Figure 1C). Smoking was most prevalent among
those aged <55 years (51.3%) and declined with age
(Figure 2C; Table S7). Approximately half the patients had
at least 2 potentially modiﬁable risk factors (Figure 3C). In
contrast with other IS subtypes, in patients with IS caused by
SVD we observed little variation in the distribution of the total
Figure 3. Number of potentially modiﬁable risk factors (obesity, hypertension, hyperlipidemia, diabetes mellitus, and smoking) present in
each age group in ischemic stroke overall (A); ischemic stroke caused by large artery atherosclerosis (B), small vessel disease (C), or
cardioembolism (D); spontaneous intracerebral hemorrhage (E); and aneurysmal subarachnoid hemorrhage (F).
DOI: 10.1161/JAHA.116.005090 Journal of the American Heart Association 6
Vascular Risk Proﬁles by Age and Stroke Subtype Hauer et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on July 25, 2017
http://jaha.ahajournals.org/
D
ow
nloaded from
 
number of risk factors present across the age groups
(Figure 3B through 3F; Table S3).
Ischemic Stroke Caused by Cardioembolism
In patients with IS caused by cardioembolism, we observed
male predominance except in patients aged ≥75 years
(Figure 1D; Table S8). The prevalence of non-white origin
showed little variation with age (Figure 2D; Table S9),
whereas obesity peaked markedly (26.9%) between 55 to
65 years (Figure 1D). In the youngest age group, hyperten-
sion (22.9%), hyperlipidemia (13.0%), and diabetes mellitus
(8.7%) were all less prevalent in comparison with either LAA or
SVD. These differences became less marked with increasing
age (Figure 1B through 1D). Smoking and a family history of
early-onset cardiovascular disease were less prevalent in all
age groups compared with patients with IS caused by either
LAA or SVD (Figure 1B through 1D). Patients with IS of
cardiac origin aged <65 years most often had <2 modiﬁable
risk factors, in particular those aged <55 years; these
differences were no longer prominent in those aged
≥65 years (Figure 3D; Table S3).
Spontaneous Intracerebral Hemorrhage
A male predominance was noticed up to 75 years of age,
but not thereafter (Figure 1E; Table S10). Patients aged
<55 years were signiﬁcantly more often of non-white origin
(21.5%) compared with the reference group (4.6%; MD,
16.9% [95% CI, 28.1 to 5.8]) (Figures 1E and 2E;
Table S11). Prevalence of obesity was considerably higher
among those aged <55 years (25.0%; MD, 11.3% [95% CI,
2.8 to 25.4]) and aged 55 to 65 years (28.0%; MD, 14.3%
[95% CI, 0.8 to 29.4]) than in the reference group (13.7%)
(Figure 2E). Hypertension was frequent among all age
groups, with prevalences rising up to 75 years of age;
thereafter, we noticed a declining prevalence. Prevalence of
hyperlipidemia and diabetes mellitus increased with age.
Again, smoking was most prevalent (34.8%) in the youngest
age group and declined with increasing age. About a third of
those aged <65 years reported a family history of early-
onset cardiovascular disease (Figure 1E). The majority of
patients aged <65 years had only one modiﬁable risk factor,
whereas approximately half of the patients aged ≥65 years
had at least 2 potentially modiﬁable risk factors (Figure 3E;
Table S3).
Aneurysmal Subarachnoid Hemorrhage
Patients with aSAH showed a strong female preponderance
(73.8%; Figure 1F; Table S12). aSAH was most pronounced in
patients aged <55 years (81.1%) and patients aged 65 to
75 years (79.7%). Patients aged <55 years were signiﬁcantly
more often of non-white origin (8.8%) as compared with the
reference group (55–65 years, 2.5%; MD, 6.2% [95% CI, 1.3–
11.2]). Smoking was prevalent in more than half of those aged
<65 years (Figure 1F) and decreased to about 40% in those
aged 65 to 75 years. In contrast, hypertension strongly
increased with age and was observed signiﬁcantly less often
(19.6%) among the youngest as compared with the reference
group (33.1%; MD, 13.5% [95% CI, 23.7 to 3.2])
(Figure 2F; Table S13). In all groups, prevalences of hyper-
lipidemia and diabetes mellitus were low and showed a
gradual increase with age. Familial occurrence of aSAH was
found stable among the age groups (8%). Regardless of age,
most patients had only one known potentially modiﬁable risk
factor, but the proportion of patients with more than one risk
factor increased with age (Figure 3F; Table S3).
Discussion
In this prospective multicenter university hospital–based
cohort in The Netherlands we found that the prevalence of
cardiovascular risk factors shows age-speciﬁc patterns
among various stroke subtypes. Except for aSAH, we found
a male predominance in all stroke subtypes, which attenu-
ated with advancing age. IS, sICH, and aSAH patients aged
<55 years were signiﬁcantly more often of non-white origin.
Obesity was present in more than one ﬁfth of patients aged
<55 years with sICH and in those with IS caused by either
LAA or SVD. Age-speciﬁc prevalences of potentially modiﬁ-
able risk factors showed a comparable pattern for LAA and
SVD. These patients more often had hypertension, hyperlipi-
demia, and diabetes mellitus than patients with IS of cardiac
origin if they were aged <55 years, but these differences
became less marked with increasing age. Accumulation of
potentially modiﬁable risk factors was generally most
pronounced in patients with LAA or SVD as compared with
patients with cardioembolic stroke. In most IS subtypes, we
observed declining prevalences of hyperlipidemia and dia-
betes mellitus in patients aged ≥75 years. In all stroke
subtypes, smoking was most prevalent among the youngest
group; the proportion of smokers being highest in patients
with aSAH.
Ischemic Stroke Overall
The declining proportion of patients with hyperlipidemia,
diabetes mellitus, and smoking in the elderly IS is in line with
previous population- and hospital-based cohorts4,7–9 and may
reﬂect mortality displacement.4 Excess (vascular-related)
mortality in patients with vascular risk factors ultimately
results in low prevalence rates among survivors. In contrast
with our ﬁndings, a Danish nationwide hospital-based cohort
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including 40 102 ﬁrst-ever IS patients found a declining
prevalence of hypertension in the elderly (>70–80 years).4 A
difference with our study is that we also included patients
with previous strokes (23.4%), in whom hypertension may
already have been diagnosed. We consistently found smoking
to be most prevalent in patients aged <55 years (43.9%). In
the nationwide study in Denmark, smoking prevalence peaked
(55%) at 50 years of age and declined rapidly thereafter,
conforming to our observation.4 Previous studies focusing on
young stroke patients found similar ﬁgures on smoking
prevalence. One study (sifap1 [Stroke in Young Fabry
Patients]) consisting of 4467 IS patients aged 18 to 55 years
reported a smoking prevalence of 55.5%,6 and another study
from Helsinki including 1008 consecutive ﬁrst-ever IS patients
aged 15 to 49 years reported a rate of 44%.5
Ischemic Stroke Caused by Large Artery
Atherosclerosis
Almost a third of patients with IS caused by LAA were obese;
this is twice as frequent as the proportion of obesity reported for
Dutch persons of similar age.14 For IS in general, a previous
study found a similar age-speciﬁc pattern.4Obesity predisposes
to the so-called metabolic syndrome,15,16 consisting of hyper-
tension, hyperlipidemia, and diabetes mellitus, which may be
reﬂected by the accumulation of risk factors observed in
patients with IS caused by LAA. Such risk factor accumulation
has been previously observed, but not speciﬁcally for IS
subtypes. The Helsinki cohort also showed accelerated accu-
mulation of traditional risk factors from the mid-40s, most
prominent in men,5,17 whereas only 5% of the young stroke
patients in sifap1 were devoid of any modiﬁable risk factor.6
Ischemic Stroke Caused by Small Vessel Disease
Female predominance in patients with IS caused by SVD aged
≥75 years likely reﬂects their longer life expectancy. Only in
this IS subtype, diabetes mellitus showed no decline in
prevalence in the elderly. In line with our study, most previous
hospital- and population-based cohorts found that hyperten-
sion, diabetes mellitus, and smoking appear equally common
in SVD and LAA and that these subtypes do not harbor
different risk proﬁles.18–21 However, by specifying the preva-
lences of risk factors for age, we observed that accumulation
of modiﬁable risk factors in the young is more pronounced in
those with SVD than in other IS subtypes.
Ischemic Stroke Caused by Cardioembolism
Patients with IS of cardiac origin aged <55 years carried less
potentially modiﬁable risk factors than those with IS caused
by LAA or SVD. This is probably explained by cardiac disorders
such as patent foramen ovale, atrial septal aneurysms, and
(inherited) cardiomyopathies that are not associated with
vascular risk factors.5,22 The observed steep rise in preva-
lence of risk factors with age in this group is compatible with
atrial ﬁbrillation as the most common source of cardioem-
bolism in the elderly and its prevalence increasing with age.23
The peaking prevalence of obesity in those aged 55 to
65 years may herald the trend of an increasing attributable
risk for atrial ﬁbrillation due to obesity.23
Spontaneous Intracerebral Hemorrhage
The ﬁnding that the proportion of patients of non-white origin
is high in the young is consistent with previous reports
showing that blacks and Hispanics have a higher risk of (deep)
sICH than white.24,25 Our ﬁnding of a trend towards higher
prevalence of obesity in those aged <65 years than in the
elderly suggests a role for unclariﬁed (age-related) metabolic
factors in sICH etiology. A previous study among 384
consecutive sICH patients aged ≥55 years found that high
BMI values >30 kg/m2 but also low values of <18.5 kg/m2
were associated with deep but not lobar ICH risk, most
prominently in men.26 Despite the frequent association
between obesity and hyperlipidemia, higher levels of total
cholesterol and particularly triglycerides have repeatedly been
suggested to protect against ICH.26,27 We noticed hyperlipi-
demia in only 12.5% of patients aged <65 years. Consistent
with previous observations,24,28 diabetes mellitus and smok-
ing, but not hypertension, were less prevalent among all age
groups with sICH than in IS.
Aneurysmal Subarachnoid Hemorrhage
Our observation of female preponderance and a high
prevalence of smoking is in line with previous observa-
tions.29–31 Hypertension, another well-established risk factor
for aSAH,30,32 was found to be least prevalent (19.6%) in the
youngest age group. Many young aSAH patients may be
unaware of preexisting hypertension at the time of hemor-
rhage since aSAH occurs at a relatively young age, often as a
ﬁrst vascular event. Familial occurrence of aSAH was found to
be stable among the different age groups, while, in contrast,
older IS and sICH patients less often reported a family history
of cardiovascular disease. A positive family history may reﬂect
the involvement of genetic risk factors in aSAH pathophys-
iology and its involvement may be regardless of age.
Alternatively, the proportion of a positive family history in
the young may be low in these patients because aSAH has yet
to occur in a next of kin, as aSAH incidence increases with
age.33
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Strengths and Limitations
Strengths of our study are its large size, prospective design,
and application of standardized phenotyping of stroke
subtypes and deﬁnitions of vascular risk factors. Our study
also has limitations. First, it represents a university hospital–
based cohort and is not population based. At the same time,
this has the advantage of our study being enriched for young
stroke patients. The observed higher proportion of non-white
among young stroke patients may be due to socioeconomic
inequalities among ethnic minority groups34 or differences in
genetic risk factors or may reﬂect the increasing number of
next-generation immigrants among the Dutch population,35
but this requires further study. Second, selection bias may
play a role in that patients with a poor prognosis may have
died before informed consent could be obtained. The sample
size of patients with sICH was limited and we were therefore
unable to distinguish lobar from nonlobar sICH, which have
different risk proﬁles.36,37 Third, assessment of IS caused by
SVD may have been prone to misclassiﬁcation since, accord-
ing to TOAST,12 support from imaging is not required. Because
hypertension and diabetes mellitus are considered supportive
for the diagnosis of SVD in the TOAST classiﬁcation, this may
have inﬂated prevalences of these risk factors.19 Fourth,
cardiovascular disease in ﬁrst-degree relatives aged
<60 years was self-reported by the patient or a next of kin
and not veriﬁed by consulting medical records.
Conclusions
We show in a large, well-phenotyped cohort that stroke
subtypes have different risk proﬁles that vary according to
age. Recognition of these patterns may guide more tailored
primary and secondary stroke prevention efforts, including
targeted prevention campaigns for speciﬁc age groups. For
example, our study emphasizes the importance of premature
atherosclerosis in the etiology of stroke in the young. Since
young stroke patients have an increased risk of vascular-
related mortality over the course of 20 years,38,39 and the
incidence of stroke in young patients is rising,40 there is a
large need for speciﬁc strategies to prevent cardiovascular
disease in these patients.
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 Table S1. Prevalence of vascular risk factors in patients with ischemic stroke 
 All ages 
n=3311 
<55 years 
n=735 
55-65 years 
n=759 
65-75 years 
n=881 
≥75 years 
n=936 
Men  1962 
(59.3) 
397 
(54.0) 
518 
(68.2) 
564 
(64.0) 
483  
(51.6) 
Non-Caucasian 139/2819 
(4.9) 
48/643 
(7.5) 
44/647 
(6.8) 
28/738 
(3.8) 
19/791  
(2.4) 
BMI ≥30 kg/m2 453/2516  
(18.0) 
107/575  
(18.6) 
118/594  
(19.9) 
141/693  
(20.3) 
87/654  
(13.3) 
Hypertension 1793/3268  
(54.9) 
238/727 
(32.7) 
413/747 
(55.3) 
532/871 
(61.1) 
610/923  
(66.1) 
Hyperlipidemia 1142/3220 
(35.5) 
154/721   
(21.4) 
259/745  
(34.8) 
379/851  
(44.5) 
350/903  
(38.8) 
Diabetes mellitus 518/3252 
(15.9) 
62/724  
(8.6) 
84/479  
(11.2) 
190/860  
(22.1) 
182/919  
(19.8) 
Smoking 914/3145 
(29.1) 
315/717 
(43.9) 
288/724  
(39.8) 
202/841  
(24.0) 
109/863 
(12.6) 
Family history 900/2438 
 (36.9) 
260/614  
(42.3) 
229/556  
(41.2) 
257/655  
(39.2) 
154/613  
(25.1) 
Data are in number (%). BMI, body mass index. 
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Table S2. Mean differences in the prevalence of vascular risk factors in patients with ischemic stroke 
 <55 years 
n=735 
55 to 65 years 
n=759 
65 to 75 years* 
n=881 
≥75 years 
n=936 
Male -10.0 (-14.8 to -5.2) 4.2 (-0.4 to 8.8) - -12.4 (-16.9 to -7.9) 
Non-Caucasian  3.7 (1.2 to 6.1) 3.0 (0.6 to 5.4) - -1.4 (-3.1 to 0.4) 
BMI ≥30 kg/m2 -1.7 (-6.1 to 2.7) -0.5 (-4.9 to 3.9) - -7.0 (-11.0 to -3.1) 
Hypertension -28.3 (-33.1 to -23.6) -5.8 (-10.6 to -1.0) - 5.0 (0.6 to 9.5) 
Hyperlipidemia -23.2 (-27.7 to -18.7) -9.8 (-14.6 to -5.0) - -5.8 (-10.4 to -1.2) 
Diabetes mellitus -13.5 (-17.0 to -10.1) -10.9 (-14.5 to -7.3) - -2.3 (-6.1 to 1.5) 
Smoking  19.9 (15.3 to 24.6) 15.8 (11.2 to 20.4) - -11.4 (-15.0 to -7.7) 
Family history 3.1 (-2.3 to 8.5) 2.0 (-3.6 to 7.5) - -14.1 (-19.2 to -9.0) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
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Table S3. Number of potentially modifiable risk factors* in stroke patients according to 
subtype 
 0 1 2 3 4 5 
Ischemic stroke        
<55 years (n=735) 27.4 37.6 22.0 8.6 3.4 1.0 
55 to 65 years (n=759) 18.8 31.2 27.4 17.1 4.2 1.3 
65 to 75 years (n=881) 18.1 28.3 25.9 19.2 7.5 1.0 
≥75 years (n=936) 18.2 32.7 30.6 14.5 3.8 0.2 
  Large artery atherosclerosis       
<55 years (n=104) 5.8 37.9 30.4 16.3 5.6 4.3 
55 to 65 years (n=207) 11.7 29.2 28.2 24.5 4.9 1.5 
65 to 75 years (n=260) 11.3 25.3 26.1 26.1 9.9 1.3 
≥75 years (n=244) 17.7 31.1 33.5 12.9 4.8 0.0 
  Small vessel disease       
<55 years (n=120) 14.9 32.3 27.0 14.6 9.9 1.3 
55 to 65 years (n=182) 13.5 35.1 27.4 18.3 3.2 2.6 
65 to 75 years (n=154) 18.8 34.4 21.9 14.0 9.1 1.9 
≥75 years (n=176) 17.7 33.1 28.1 16.5 4.5 0.2 
  Cardioembolic stroke       
<55 years (n=70) 40.7 40.6 12.3 5.0 1.6 0.0 
55 to 65 years (n=75) 22.3 33.1 25.6 15.1 4.1 0.0 
65 to 75 years (n=122) 20.7 24.9 30.4 17.0 6.9 0.1 
≥75 years (n=202) 17.7 35.1 34.0 12.2 1.1 0.0 
Spontaneous intracerebral 
hemorrhage 
      
<55 years (n=73) 18.2 51.6 22.1 6.2 1.4 0.7 
55 to 65 years (n=65) 22.5 46.5 18.0 10.2 3.2 0.0 
65 to 75 years (n=98) 16.2 29.7 32.2 19.4 2.6 0.0 
≥75 years (n=58) 20.9 30.7 32.8 10.9 5.0 0.0 
Aneurysmal subarachnoid 
hemorrhage 
      
<55 years (n=196) 24.1 56.3 13.9 4.7 1.1 0.0 
55 to 65 years (n=119) 24.5 46.7 11.4 11.2 5.0 1.4 
65 to75 years (n=74) 20.9 42.6 24.2 10.7 1.8 0.0 
≥75 years (n=36) 9.2 46.7 24.9 11.3 8.2 0.0 
Data are in percentage. n=number.   
* Obesity, hypertension, hyperlipidemia, diabetes mellitus and smoking.  
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 Table S4. Prevalence of vascular risk factors in patients ischemic stroke caused by large 
artery atherosclerosis   
 All ages 
n=817 
<55 years 
n=104 
55-65 years 
n=207 
65-75 years 
n=260 
≥75 years 
n=244 
Men  543  
(66.5) 
55 
(52.9) 
160 
 (77.2) 
183 
 (70.4) 
145  
(58.9) 
Non-Caucasian 22/734  
(3.0) 
3/99  
(3.0) 
9/189  
(4.8) 
6/227  
(2.6) 
4/219  
(1.8) 
BMI ≥30 kg/m2 129/641  
(20.1) 
23/76 
(30.3) 
31/175 
(17.7) 
48/216 
(22.2) 
27/174  
(15.5) 
Hypertension 502/805  
(62.4) 
53/101 
(52.5) 
127/206  
(61.7) 
161/258  
(62.4) 
161/240 
(67.1) 
Hyperlipidemia 352/796  
(44.2) 
29/101 
(28.7) 
81/204  
(39.7) 
139/252  
(55.2) 
103/239 
(43.1) 
Diabetes mellitus 140/805  
(17.4) 
16/102 
(15.7) 
22/205  
(10.7) 
66/257  
(25.7) 
36/241  
(14.9) 
Smoking 305/794 
(38.4) 
67/103 
(65.0) 
114/202  
(56.4) 
93/257  
(36.2) 
31/232  
(13.4) 
Family history 247/624  
(39.6) 
45/81 
 (55.6) 
65/157  
(41.1) 
88/209  
(42.1) 
49/177  
(27.7) 
Data are in number (%). BMI, body mass index. 
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Table S5. Mean differences in the prevalence of vascular risk factors in patients with ischemic stroke caused by large artery atherosclerosis  
 <55 years 
n=104 
55 to 65 years 
n=207 
65 to 75 years* 
n=260 
≥75 years 
n=244 
Male -17.5 (-28.7 to -6.3) 6.9 (-1.1 to 14.9) - -11.4 (-19.7 to -3.0) 
Non-Caucasian  0.4 (-3.5 to 4.3) 2.1 (-1.6 to 5.8) - -0.8 (-3.6 to 2.0) 
BMI ≥30 kg/m2 8.0 (-3.9 to 19.9) -4.5 (-12.5 to 3.5) - -6.7 (-14.5 to 1.1) 
Hypertension -9.9 (-21.2 to 1.4) -0.8 (-9.7 to 8.2) - 4.4 (-4.0 to 12.9) 
Hyperlipidemia -26.4 (-37.3 to -15.6) -15.5 (-24.6 to -6.3) - -11.7 (-20.5 to -2.9) 
Diabetes mellitus -10.0 (-18.9 to -1.1) -14.9 (-21.8 to -8.1) - -10.6 (-17.7 to -3.6) 
Smoking  28.9 (17.8 to 39.9) 20.2 (11.2 to 29.3) - -23.1 (-30.5 to -15.8) 
Family history 13.5 (0.7 to 26.2) -0.7 (-11.0 to 9.6) - -14.1 (-23.6 to -4.6) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
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Table S6. Prevalence of vascular risk factors in patients with ischemic stroke caused by small 
vessel disease  
 All ages 
n=632 
<55 years 
n=120 
55-65 years 
n=182 
65-75 years 
n=154 
≥75 years 
n=176 
Men  347 (54.9) 70 (58.3) 120 (65.6) 79 (51.3) 78 (44.3) 
Non-Caucasian 31/514  
(6.0) 
10/98  
(10.2) 
11/153  
(7.2) 
7/123  
(5.7) 
3/140  
(2.1) 
BMI ≥30 kg/m2 86/468  
(18.4) 
26/92  
(28.3) 
18/125  
(14.4) 
24/120  
(20.0) 
18/131  
(13.7) 
Hypertension 366/630 
(58.1) 
54/118  
(45.8) 
104/182  
(57.1) 
94/154  
(61.0) 
114/176 
(64.8) 
Hyperlipidemia 236/624 
(37.3) 
38/117  
(32.5) 
71/182 
 (39.0) 
60/151  
(39.7) 
67/174  
(38.5) 
Diabetes mellitus 129/627 
(20.6) 
22/118  
(18.6) 
33/183  
(18.0) 
33/151  
(21.9) 
41/175  
(23.4) 
Smoking 182/600 
(30.3) 
60/117  
(51.3) 
69/181  
(38.1) 
30/142  
(21.1) 
23/160  
(14.4) 
Family history 170/472 
(36.0) 
43/97  
(44.3) 
53/139  
(38.1) 
45/116 
(38.8) 
29/120  
(24.2) 
Data are in number (%). BMI, body mass index. 
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Table S7. Mean differences in the prevalence of vascular risk factors in patients with ischemic stroke caused by small vessel disease  
 <55 years 
n=120 
55-65 years 
n=182 
65-75 years* 
n=154 
≥75 years 
n=176 
Male  7.0 (-4.9 to 19.0) 14.1 (3.5 to 24.7) - -7.0 (-17.8 to 3.9) 
Non-Caucasian  4.5 (-2.8 to 11.9) 1.5 (-4.4 to 7.5) - -3.5 (-8.3 to 1.2) 
BMI ≥30 kg/m2 8.3 (-3.5 to 20.1) -5.6 (-15.1 to 3.9) - -6.3 (-15.6 to 3.1) 
Hypertension -15.3 (-27.2 to -3.3) -3.6 (-14.2 to 7.0) - 3.7 (-6.8 to 14.2) 
Hyperlipidemia -7.3 (-18.9 to 4.4) -0.5 (-11.1 to 10.1) - -1.2 (-11.9 to 9.5) 
Diabetes mellitus -3.2 (-13.0 to 6.6) -3.7 (-12.4 to 4.9) - 1.6 (-7.6 to 10.8) 
Smoking  30.2 (18.8 to 41.5) 17.2 (7.4 to 27.0) - -6.8 (-15.5 to 2.0) 
Family history 5.5 (-7.9 to 18.9) -0.4 (-12.5 to 11.7) - -14.6 (-26.5 to -2.8) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
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Table S8. Prevalence of vascular risk factors in patients with cardioembolic stroke 
 All ages 
n=469 
<55 years 
n=70 
55-65 years 
n=75 
65-75 years 
n=122 
≥75 years 
n=202 
Men  284  
(60.6) 
43  
(61.4) 
53  
(70.7) 
84 
(68.9) 
104  
(51.5) 
Non-Caucasian 16/394  
(4.1) 
3/59  
(5.1) 
4/60  
(6.7) 
5/101  
(5.0) 
4/174  
(3.3) 
BMI ≥30 kg/m2 56/345  
(16.2) 
10/61  
(16.4) 
18/67  
(26.9) 
14/82 
(17.1) 
14/135 
(10.4) 
Hypertension 273/462  
(59.1) 
16/70  
(22.9) 
42/74  
(56.8) 
75/118  
(63.6) 
140/200 
(70.0) 
Hyperlipidemia 142/446  
(31.8) 
9/69 
(13.0) 
24/73  
(32.9) 
50/112  
(44.6) 
59/192  
(30.7) 
Diabetes mellitus 76/453  
(16.8) 
6/69  
(8.7) 
4/73 
(5.5) 
26/114  
(22.8) 
40/197  
(20.3) 
Smoking 70/441  
(15.9) 
17/68  
(25.0) 
18/71 
 (25.4) 
17/113 
(15.0) 
18/189  
(9.5) 
Family history 85/323  
(26.3) 
18/61 
(29.5) 
19/58 
(32.8) 
25/79 
(31.6) 
23/125  
(18.4) 
Data are in number (%). BMI, body mass index.  
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Table S9. Mean differences in the prevalence of vascular risk factors in patients with cardioembolic stroke 
 <55 years 
n=70 
55 to 65 years 
n=75 
65 to 75 years* 
n=121 
≥75 years 
n=201 
Male -8.0 (-22.3 to 6.3) 1.2 (-12.1 to 14.6) - -17.7 (-28.5 to -6.9) 
Non-Caucasian  0.1 (7.0 to 7.2) 1.7 (-5.8 to 9.1) - -2.7 (-7.6 to 2.2) 
BMI ≥30 kg/m2 -0.7 (-13.3 to 11.9) 9.8 (-3.8 to 23.4) - -6.7 (-16.5 to 3.1) 
Hypertension -40.4 (-53.7to -27.1) -6.5 (-20.8 to 7.9) - 6.6 (-4.3 to 17.5) 
Hyperlipidemia -31.6 (-43.9 to -19.3) -11.8 (-26.1 to 2.6) - -14.3 (-25.7 to -2.9) 
Diabetes mellitus -14.1 (-24.4 to -3.8) -17.3 (-26.7 to -7.9) - -2.9 (-12.4 to 6.6) 
Smoking  9.8 (-2.6 to 22.3) 10.2 (-2.1 to 22.5) - -5.6 (-13.5 to 2.3) 
Family history -2.1 (-17.8 to 13.5) 1.1 (-15.0 to 17.2) - -13.2 (-25.7 to -0.8) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
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Table S10. Prevalence of vascular risk factors in patients with spontaneous intracerebral 
hemorrhage 
 All ages 
n=294 
<55 years 
n=73 
55-65 years 
n=65 
65-75 years 
n=98 
≥75 years 
n=58 
Men  178 (60.5) 46 (63.0) 41 (63.1) 64 (65.3) 27 (46.6) 
Non-Caucasian 23/263  
(8.7) 
14/65  
(21.5) 
3/58  
(5.2) 
4/87  
(4.6) 
2/53 
(3.8) 
BMI ≥30 kg/m2 41/219  
(18.7) 
14/56  
(25.0) 
14/50  
(28.0) 
10/73  
(13.7) 
3/40  
(7.5) 
Hypertension 173/293  
(59.0) 
35/73  
(47.9) 
33/64  
(51.6) 
69/98  
(70.4) 
36/58  
(62.1) 
Hyperlipidemia 75/288  
(26.0) 
7/72  
(9.7) 
10/64  
(15.6) 
36/95  
(37.9) 
88/57 
(38.6) 
Diabetes mellitus 35/294  
(11.9) 
5/73  
(6.8) 
3/65  
(4.6) 
17/98 
(17.3) 
10/58  
(17.2) 
Smoking 68/272  
(25.0) 
24/69 
(34.8) 
18/63 
(28.6) 
18/87 
(20.7) 
8/53 
(15.1) 
Family history 51/182  
(28.0) 
18/54 
(33.3) 
13/42  
(31.0) 
13/56 
(23.2) 
7/30 
(23.3) 
Data are in number (%). BMI, body mass index. 
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Table S11. Mean differences in the prevalence of vascular risk factors in patients with spontaneous intracerebral hemorrhage  
 <55 years 
n=73 
55 to 65 years 
n=65 
65 to 75 years* 
n=98 
≥75 years 
n=58 
Male -2.3 (-17.0 to 12.4) -2.2 (-17.4 to 13.0) - -18.8 (-35.0 to -2.5) 
Non-Caucasian  16.9 (5.8 to 28.1) 0.6 (-6.7 to 7.8) - -0.8 (-7.9 to 6.2) 
BMI ≥30 kg/m2 11.3 (-2.8 to 25.4) 14.3 (-0.8 to 29.4) - -6.2 (-17.8 to 5.4) 
Hypertension -22.5 (-37.1 to -7.7) -18.8 (-34.3 to -3.4) - -8.3 (-24.0 to 7.4) 
Hyperlipidemia -28.2 (-40.3 to -16.1) -22.3 (-35.7 to -8.9) - 0.7 (-15.6 to 17.0) 
Diabetes mellitus -10.5 (-20.1 to -0.9) -12.7 (-21.9 to -3.5) - -0.1 (-12.6 to 12.4) 
Smoking  14.1 (-0.2 to 28.4) 7.9 (-6.4 to 22.2) - -5.6 (-19.1 to 7.9) 
Family history 10.1 (-6.9 to 27.2) 7.7 (-10.5 to 26.0) - 0.1 (-19.1 to 19.4) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
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Table S12. Prevalence of vascular risk factors in patients with aneurysmal subarachnoid 
hemorrhage 
 All ages 
n=428 
<55 years 
n=196 
55 65 years 
n=119 
65-75 
years 
n=74 
≥75 years 
n=39 
Men  112 (26.2) 39 (19.9) 44 (37.0) 15 (20.3) 14 (35.9) 
Non-Caucasian 25/425  
(5.9) 
17/194 
(8.8) 
3/119  
(2.5) 
5/73  
(6.8) 
0/39  
(0.0) 
BMI ≥30 kg/m2 53/373  
(14.2) 
22/172  
(12.8) 
15/104 
(14.4) 
11/62  
(17.7) 
5/35 
(14.3) 
Hypertension 136/31.8  
(32.1) 
38/194  
(19.6) 
39/118  
(33.1) 
31/73  
(42.5) 
28/39 
 (71.8) 
Hyperlipidemia 60/420  
(14.3) 
10/194  
(5.2) 
20/116  
(17.2) 
17/72  
(23.6) 
13/38 
 (34.2) 
Diabetes mellitus 20/427  
(4.7) 
5/196 
 (2.6) 
7/119  
(5.9) 
3/73 
 (4.1) 
5/39  
(12.8) 
Smoking 219/405  
(54.1) 
119/191  
(62.3) 
65/113  
(57.5) 
27/68 
(39.7) 
8/33 
(24.2) 
Family history* 27/328  
(8.2) 
13/163  
(8.0) 
8/85  
(9.4) 
4/57  
(7.0) 
2/23  
(8.7) 
Data are in number (%). BMI, body mass index. 
* A first degree relative with a past subarachnoid hemorrhage was considered as familial 
occurrence. 
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Table S13. Mean differences in the prevalence of vascular risk factors in patients with aneurysmal subarachnoid hemorrhage  
 <55 years 
n=196 
55 to 65 years* 
n=119 
65 to 75 years 
n=74 
≥75 years 
n=36 
Male -17.1 (-27.5 to -6.7) - -16.7 (-29.5 to -3.9) -1.0 (-18.8 to 16.6) 
Non-Caucasian  6.2 (1.3 to 11.2) - 4.3 (-1.5 to 10.2) -2.5 (-5.4 to 0.3) 
BMI ≥30 kg/m2 -1.6 (-10.0 to 6.7) - 3.3 (-8.3 to 14.9) -0.1 (-13.8 to 13.5) 
Hypertension -13.5 (-23.7 to -3.2) - 9.4 (-4.7 to 23.8) 38.7 (21.7 to 55.8) 
Hyperlipidemia -12.1 (-19.7 to -4.5) - 6.4 (-5.8 to 18.5) 17.0 (-0.2 to 34.1) 
Diabetes mellitus -3.3 (-7.7 to 1.0) - -1.8 (-8.3 to 4.8) 6.9 (-4.8 to 18.7) 
Smoking 4.8 (-6.7 to 16.2) - -17.8 (-32.8 to -2.8) -33.3 (-51.1 to -15.5) 
Family history† -1.4 (-8.8 to 5.9) - -2.4 (-11.9 to 7.1) -0.7 (-14.3 to 12.9) 
Data are in mean with 95% corresponding confidence intervals. BMI, body mass index.  
* This age category was used as reference. 
† First degree relative with a past subarachnoid hemorrhage.  
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